![]() |
市場調查報告書
商品編碼
1621347
帶狀皰疹疫苗市場:按產品、類型和分銷管道 - 2025-2030 年全球預測Shingles Vaccine Market by Product (SkyZoster, Zostavax, Shingrix), Type (Live Attenuated Vaccine, Recombinant Vaccine), Distribution Channel - Global Forecast 2025-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
帶狀皰疹疫苗市場 2023 年估值為 17.3 億美元,預計 2024 年將達到 18.7 億美元,複合年成長率為 8.11%,到 2030 年將達到 29.9 億美元。
全球帶狀皰疹疫苗市場的定義特別著重於預防 50 歲及以上族群的帶狀皰疹感染。帶狀皰疹是由水痘帶狀皰疹病毒(水痘)重新運作引起的,需要接種疫苗以減少帶狀皰疹後遺症神經痛等嚴重併發症。這個市場是由老年人口的增加、疾病意識的增強以及疫苗技術的進步所推動的。主要應用包括老年保健和免疫力缺乏患者管理。最終用戶採用範圍包括醫院、診所和專業醫療中心。成長要素包括積極的政府措施、有利的報銷政策和醫療保健支出的增加。機會存在於疫苗接種率低的新興市場、增加疫苗庫存目標的機會以及創新交付方法的夥伴關係。目前的建議是擴大教育計畫以提高吸收率,並採取針對高風險族群的行銷策略。然而,高昂的製造成本、較高的監管障礙以及對疫苗安全性的懷疑正在阻礙市場的快速滲透。此外,還存在疫苗分配中的物流問題、疫苗猶豫的影響以及在醫療保健產品方面享有盛譽的大型製藥公司的競爭等挑戰。值得關注的創新領域包括探索長效疫苗配方、改善免疫反應的新佐劑系統,以及可提供更快生產時間和擴充性的基於 mRNA 的疫苗技術。策略性措施包括聯合研發和投資基因工程疫苗,以提供全面的保護,同時最大限度地減少副作用。儘管市場競爭激烈,有GlaxoSmithKline Plc和默克等大公司的存在,但該公司可以透過利用疫苗開發中的人工智慧等技術進步,在不斷成長的領域中開拓出一席之地。潛力。
主要市場統計 | |
---|---|
基準年[2023] | 17.3億美元 |
預計年份 [2024] | 18.7億美元 |
預測年份 [2030] | 29.9億美元 |
複合年成長率(%) | 8.11% |
市場動態:快速發展的帶狀皰疹疫苗市場的關鍵市場洞察
帶狀皰疹疫苗市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。
波特的五力:駕馭帶狀皰疹疫苗市場的策略工具
波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。
PESTLE分析:了解帶狀皰疹疫苗市場的外部影響
外部宏觀環境因素在塑造帶狀皰疹疫苗市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。
市場佔有率分析 了解帶狀皰疹疫苗市場的競爭格局
帶狀皰疹疫苗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。
FPNV 定位矩陣帶狀皰疹疫苗市場供應商的績效評估
FPNV 定位矩陣是評估帶狀皰疹疫苗市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。
策略分析和建議描繪帶狀皰疹疫苗市場的成功之路
對於旨在加強其在全球市場的影響力的公司來說,帶狀皰疹疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。
1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。
2. 市場開發:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。
3. 市場多元化:分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。
4. 競爭評估與情報:全面分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。
5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。
1.目前的市場規模和未來的成長預測是多少?
2. 哪些產品、區隔市場和地區提供最佳投資機會?
3.塑造市場的主要技術趨勢和監管影響是什麼?
4.主要廠商的市場佔有率和競爭地位如何?
5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?
The Shingles Vaccine Market was valued at USD 1.73 billion in 2023, expected to reach USD 1.87 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 2.99 billion by 2030.
The global shingles vaccine market is defined by its focus on the prevention of herpes zoster infections, particularly among individuals aged 50 and above. Shingles, caused by the reactivation of the varicella-zoster virus (chickenpox), necessitates vaccination to mitigate severe complications such as postherpetic neuralgia. The market is driven by an increasing aged population, rising awareness about the disease, and advancements in vaccine technology. Key applications include its use in elderly healthcare and immunocompromised patient management. End-user adoption spans across hospitals, clinics, and specialty healthcare centers. Growth factors include robust government initiatives, favorable reimbursement policies, and escalating healthcare expenditure. Opportunities arise from emerging markets with low vaccination rates, opportunities for enhanced vaccine strain targeting, and partnerships for innovative delivery methods. Current recommendations focus on expanding educational programs to boost uptake and employing targeted marketing strategies to reach high-risk demographics. However, limitations include high production costs, stringent regulatory hurdles, and public skepticism over vaccine safety that may hamper rapid market penetration. Additional challenges involve logistical issues in vaccine distribution, impact of vaccine hesitancy, and competition from existing pharmaceutical giants with entrenched healthcare products. Remarkable areas for innovation include research into long-lasting vaccine formulations, novel adjuvant systems to improve immune response, and mRNA-based vaccine technologies, which can offer faster production times and scalability. The strategic movement involves collaborative R&D and investment in genetically engineered vaccines that provide comprehensive coverage with minimal side effects. The market exhibits a competitive nature marked by the presence of major players like GlaxoSmithKline and Merck & Co., but it also presents a dynamic landscape with potential for new entrants who can leverage technological advancements, such as artificial intelligence for vaccine development, to carve out a niche in a growing sector.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.73 billion |
Estimated Year [2024] | USD 1.87 billion |
Forecast Year [2030] | USD 2.99 billion |
CAGR (%) | 8.11% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Shingles Vaccine Market
The Shingles Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
Porter's Five Forces: A Strategic Tool for Navigating the Shingles Vaccine Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Shingles Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Shingles Vaccine Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Shingles Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Shingles Vaccine Market
A detailed market share analysis in the Shingles Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Shingles Vaccine Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Shingles Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Shingles Vaccine Market
A strategic analysis of the Shingles Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Shingles Vaccine Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Barinthus Biotherapeutics plc, Bavarian Nordic, Biogenetech Co., Ltd., CanSino Biologics Inc., CSL Limited, Curevo Inc., Daiichi Sankyo Company, Limited, Dynavax Technologies Corporation, Emergent Biosolutions Inc., GeneOne Life Science, Inc., Gilead Sciences, Inc., GlaxoSmithKline PLC, Inovio Pharmaceuticals, Inc., JCR Pharmaceuticals Co., Ltd., Jiangsu Recbio Technology Co., Ltd., Merck KGaA, Moderna, Inc., Pfizer Inc., Sanofi S.A., Sinovac Biotech Ltd., SK Chemicals, Takeda Pharmaceutical Company Limited, Valneva SE, and VBI Vaccines Inc..
Market Segmentation & Coverage
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?